INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "TREATMENT OF NEURODEGENERATIVE DISEASES"

GENEVA, Feb. 3 -- ASTRAZENECA AB (151-85 Sodertalje) filed a patent application (PCT/IB2024/057032) for "TREATMENT OF NEURODEGENERATIVE DISEASES" on Jul 19, 2024. With publication no. WO/2025/022280, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FREEMAN, Adrian Mark (c/o AstraZeneca UK Limited1 Francis Crick AvenueCambridge Biomedical CampusCambridge Cambridgeshire CB2 0AA), PERKINTON, Michael (c/o MedImmune Limited1 Francis Crick AvenueCambridge Biomedical CampusCambridge Cambridgeshire CB2 0AA), TSAFOU, Kalliopi (c/o ...